Fulvio Lonardo
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 5%
- Cancer Research top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Harvey I. PassMarc LadanyiEthan DmitrovskyValerie W. RuschAnil WaliJohn H. HealeyJohn LangenfeldAnn G. Schwartz
- Topics
- Cancer-related Molecular Pathways (13 papers)HER2/EGFR in Cancer Research (11 papers)Head and Neck Cancer Studies (11 papers)
- Partner nations
- United StatesItalyNorway
In The Last Decade
Fulvio Lonardo
78 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 113
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.4k
- Molecular Biology 1.3k
- Cancer Research 457
- Radiology, Nuclear Medicine and Imaging 346
Countries citing papers authored by Fulvio Lonardo
This map shows the geographic impact of Fulvio Lonardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fulvio Lonardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fulvio Lonardo more than expected).
Fields of papers citing papers by Fulvio Lonardo
This network shows the impact of papers produced by Fulvio Lonardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fulvio Lonardo. The network helps show where Fulvio Lonardo may publish in the future.
Co-authorship network of co-authors of Fulvio Lonardo
This figure shows the co-authorship network connecting the top 25 collaborators of Fulvio Lonardo. A scholar is included among the top collaborators of Fulvio Lonardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fulvio Lonardo. Fulvio Lonardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 18 | |
| 3 | 10 | |
| 4 | 60 | |
| 5 | 26 | |
| 6 | 64 | |
| 7 | 29 | |
| 8 | Role of Ubiquitin-proteasome proteolytic pathway in malignant pleural mesothelioma. | 1 |
| 9 | 14 | |
| 10 | 18 | |
| 11 | 22 | |
| 12 | PICOT gene expression levels can predict survival and recurrence among malignant pleural mesothelioma patients | 1 |
| 13 | 10 | |
| 14 | 34 | |
| 15 | 92 | |
| 16 | 84 | |
| 17 | erbB-2 autophosphorylation is required for mitogenic action and high-affinity substrate coupling. | 15 |
| 18 | 49 | |
| 19 | 46 | |
| 20 | The role of autophosphorylation in modulation of erbB-2 transforming function. | 50 |
About Fulvio Lonardo
Fulvio Lonardo is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 79 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (13 papers), HER2/EGFR in Cancer Research (11 papers) and Head and Neck Cancer Studies (11 papers). The work is most often cited by research in Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Otorhinolaryngology (142 citations). Fulvio Lonardo has collaborated with scholars based in United States, Italy and Norway. Frequent co-authors include Harvey I. Pass, Marc Ladanyi, Ethan Dmitrovsky, Valerie W. Rusch, Anil Wali, John H. Healey, John Langenfeld, Ann G. Schwartz, Michele Carbone and George H. Yoo. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.